Hematopoietic progenitor kinase 1 (HPK1) negatively regulates prostaglandin E2-induced fos gene transcription
- PMID: 12522005
- DOI: 10.1182/blood-2002-07-2316
Hematopoietic progenitor kinase 1 (HPK1) negatively regulates prostaglandin E2-induced fos gene transcription
Abstract
Prostaglandin E(2) (PGE(2)) is the predominant eicosanoid product released by macrophages at the site of inflammation. Binding of PGE(2) to its cognate 7 transmembrane-spanning G protein-coupled receptors (GPCRs) activates signaling pathways, leading to the synthesis of the Fos transcription factor. Because the Ste20 serine/threonine protein kinase (S/TPK) is a critical signal transducer for the G protein-coupled pheromone receptor in Saccharomyces cerevisiae, we postulated that the PGE(2) GPCRs may activate one of the Ste20 mammalian orthologs. We demonstrate here that the catalytic activity of a hematopoietic cell-restricted, Ste20-related S/TPK, HPK1, is positively regulated by exposure to physiological concentrations of PGE(2). Furthermore, ectopic expression studies implicated HPK1 as a negative regulator of PGE(2)-induced transcription of the fos gene. Our data suggest that PGE(2)-induced activation of HPK1 may represent a novel negative regulatory pathway capable of modulating PGE(2)-mediated gene transcription.
Similar articles
-
HPK1 as a novel target for cancer immunotherapy.Immunol Res. 2012 Dec;54(1-3):262-5. doi: 10.1007/s12026-012-8319-1. Immunol Res. 2012. PMID: 22477524 Review.
-
Prostaglandin E2 activates HPK1 kinase activity via a PKA-dependent pathway.J Biol Chem. 2007 Nov 30;282(48):34693-9. doi: 10.1074/jbc.M707425200. Epub 2007 Sep 25. J Biol Chem. 2007. PMID: 17895239
-
Mechanism of prostaglandin (PG)E2-induced prolactin expression in human T cells: cooperation of two PGE2 receptor subtypes, E-prostanoid (EP) 3 and EP4, via calcium- and cyclic adenosine 5'-monophosphate-mediated signaling pathways.J Immunol. 2004 Nov 15;173(10):5952-62. doi: 10.4049/jimmunol.173.10.5952. J Immunol. 2004. PMID: 15528329
-
Prostaglandin E2 stimulates human lung carcinoma cell growth through induction of integrin-linked kinase: the involvement of EP4 and Sp1.Cancer Res. 2009 Feb 1;69(3):896-904. doi: 10.1158/0008-5472.CAN-08-2677. Epub 2009 Jan 27. Cancer Res. 2009. PMID: 19176380
-
Hematopoietic Progenitor Kinase 1 in Tumor Immunology: A Medicinal Chemistry Perspective.J Med Chem. 2022 Jun 23;65(12):8065-8090. doi: 10.1021/acs.jmedchem.2c00172. Epub 2022 Jun 13. J Med Chem. 2022. PMID: 35696642 Review.
Cited by
-
HPK1 Dysregulation-Associated NK Cell Dysfunction and Defective Expansion Promotes Metastatic Melanoma Progression.Adv Sci (Weinh). 2024 Aug;11(29):e2400920. doi: 10.1002/advs.202400920. Epub 2024 Jun 3. Adv Sci (Weinh). 2024. PMID: 38828677 Free PMC article.
-
Identification of Potent Reverse Indazole Inhibitors for HPK1.ACS Med Chem Lett. 2021 Mar 1;12(3):459-466. doi: 10.1021/acsmedchemlett.0c00672. eCollection 2021 Mar 11. ACS Med Chem Lett. 2021. PMID: 33738073 Free PMC article.
-
A perspective on HPK1 as a novel immuno-oncology drug target.Elife. 2020 Sep 8;9:e55122. doi: 10.7554/eLife.55122. Elife. 2020. PMID: 32896273 Free PMC article. Review.
-
Critical role of kinase activity of hematopoietic progenitor kinase 1 in anti-tumor immune surveillance.PLoS One. 2019 Mar 26;14(3):e0212670. doi: 10.1371/journal.pone.0212670. eCollection 2019. PLoS One. 2019. PMID: 30913212 Free PMC article.
-
HPK1 as a novel target for cancer immunotherapy.Immunol Res. 2012 Dec;54(1-3):262-5. doi: 10.1007/s12026-012-8319-1. Immunol Res. 2012. PMID: 22477524 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases

